GO:0048239 negative regulation of DNA recombination at telomere: Telomere Stability, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048239 describes any process that stops, prevents, or reduces the frequency, rate or extent of genetic recombination within the telomere [QuickGO definition].
• Telomere recombination, including homologous recombination and break-induced replication, is a major alternative lengthening of telomeres (ALT) mechanism in cancer cells.
• Proteins such as Rad27, SLFN11, Ku80, and TERT directly suppress telomere recombination and maintain telomere integrity.
• Loss of negative regulation at telomeres leads to telomere dysfunction, genomic instability, and is implicated in cancers and premature aging syndromes.
• Epigenetic modifications and R-loop resolution are emerging as key layers of negative regulation of telomeric recombination.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of genes in this process.
Description
Telomeres are specialized nucleoprotein structures that protect chromosome ends and prevent them from being recognized as DNA double-strand breaks. Uncontrolled recombination within telomeres can lead to telomere lengthening, chromosomal instability, and cellular immortalization, a hallmark of cancer. The Gene Ontology term GO:0048239, negative regulation of DNA recombination at telomere, captures the biological processes that actively suppress such recombination events [QuickGO]. Understanding this term is critical for researchers studying telomere maintenance, alternative lengthening of telomeres (ALT), and genome stability. This article integrates authoritative QuickGO data with real PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease links, and experimental models relevant to GO:0048239.
negative regulation of DNA recombination at telomere At A Glance
| GO ID | GO:0048239 |
|---|---|
| GO term | negative regulation of DNA recombination at telomere |
| Ontology | biological_process |
| Synonym | down regulation of telomeric recombination at telomere; inhibition of telomeric recombination at telomere; suppression of telomeric recombination at telomere |
| Major function | Suppresses genetic recombination within telomeres to maintain telomere stability and prevent aberrant lengthening |
| Related processes | Telomere maintenance, homologous recombination, alternative lengthening of telomeres (ALT), DNA repair |
| Key regulators | Rad27, SLFN11, Ku80, TERT, R-loop processing factors |
| Disease relevance | Cancer, premature aging, genomic instability syndromes |
What Is GO:0048239?
GO:0048239 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of genetic recombination within the telomere. It encompasses molecular activities that inhibit homologous recombination, break-induced replication, and other homology-based exchange events at chromosome ends, thereby preserving telomere integrity and preventing aberrant telomere elongation [QuickGO].
Why Is negative regulation of DNA recombination at telomere Important in Cell Biology?
Negative regulation of DNA recombination at telomeres is essential for genome stability. In its absence, telomeres become hotspots for aberrant recombination, leading to telomere length heterogeneity, chromosomal fusions, and breakage-fusion-bridge cycles that drive tumorigenesis. This process is particularly relevant for cancers that utilize the ALT pathway, where recombination-based telomere elongation sustains immortalization. Understanding GO:0048239 provides insights into fundamental telomere biology and identifies therapeutic targets for cancers and aging-related diseases.
• Prevents aberrant telomere lengthening that could otherwise support unlimited cell proliferation.
• Maintains telomere length homeostasis and protects chromosome ends from fusion and degradation.
• Suppresses homologous recombination at telomeres, a key mechanism in ALT cancers.
• Involves R-loop resolution by factors like Rad27 to prevent RNA-DNA hybrid-induced recombination.
• Is modulated by epigenetic changes during meiosis and development.
• Dysregulation is linked to cancer, premature aging, and telomere dysfunction syndromes.
• Provides potential therapeutic targets for ALT-positive tumors.
• Requires coordinated action of DNA repair proteins, helicases, and telomere-binding factors.
• Can be studied using CRISPR-based gene editing to dissect causal roles.
• Relevant across species from yeast to humans, enabling comparative studies.
What Happens During negative regulation of DNA recombination at telomere?
Recognition and Binding of Telomere-Associated Proteins
In simple terms: Special proteins bind to telomeres and act as guards that block recombination.
The first step in negative regulation involves the recruitment of shelterin components and associated factors such as Ku80 and TERT to telomeres. These proteins recognize telomeric DNA and form a protective cap that physically prevents recombination machinery from accessing chromosome ends. In Ustilago maydis, recombination and repair proteins contribute to telomere maintenance in both telomerase-positive and negative backgrounds, highlighting conserved roles.
Suppression of Homologous Recombination and Break-Induced Replication
In simple terms: The cell actively stops the molecular machinery that would otherwise swap or copy DNA at chromosome tips.
Negative regulation inhibits homologous recombination (HR) and break-induced replication (BIR) at telomeres. SLFN11 has been shown to put the brakes on alternative lengthening of telomeres, a recombination-based mechanism. Similarly, proteins like Rad27 cleave RNA in R-loop structures to suppress telomere recombination, preventing RNA-DNA hybrids from initiating HR.
Resolution of R-Loops and RNA-DNA Hybrids
In simple terms: The cell removes sticky RNA-DNA hybrids that could otherwise trigger unwanted DNA swapping.
R-loops, three-stranded nucleic acid structures consisting of RNA-DNA hybrids and displaced single-stranded DNA, can stimulate recombination. Flap endonuclease Rad27 (FEN1 in humans) cleaves the RNA moiety of R-loops at telomeres, thereby suppressing telomere recombination. This represents a key negative regulatory mechanism that maintains telomere stability.
Epigenetic and Chromatin-Based Regulation
In simple terms: Chemical tags on DNA and histones can tighten or loosen the telomere region, affecting recombination.
Epigenetic modifications, including histone methylation and acetylation, influence the accessibility of telomeric chromatin to recombination factors. During meiosis, epigenetic regulation modulates crossover frequency and distribution, including at telomeres. These chromatin states can either promote or inhibit recombination, and their dysregulation may lead to telomere dysfunction.
Coordination with Telomerase and Alternative Lengthening Pathways
In simple terms: The cell balances telomerase activity and recombination-based lengthening to keep telomeres stable.
Negative regulation of telomere recombination is tightly coordinated with telomerase activity. In telomerase-negative cells, ALT pathways can emerge, but negative regulators such as SLFN11 suppress them. Telomerase regulation itself is influenced by cell fate decisions, and its interplay with recombination pathways determines telomere maintenance outcomes. In Leishmania mexicana, Ku80 and TERT are involved in alternative lengthening mechanisms, showing evolutionary conservation.
Key Genes Involved in GO:0048239 negative regulation of DNA recombination at telomere
The following genes and proteins have been experimentally implicated in the negative regulation of DNA recombination at telomeres, based on real PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAD27 | Flap endonuclease that cleaves RNA in R-loops to suppress telomere recombination | Studied in Saccharomyces cerevisiae; loss leads to increased telomere recombination |
| SLFN11 | Suppresses alternative lengthening of telomeres (ALT) by inhibiting recombination | Identified as a brake on ALT in cancer cells; potential therapeutic target |
| KU80 | Telomere end-binding protein; involved in non-homologous end joining and telomere protection | Contributes to telomere maintenance in Ustilago maydis and Leishmania |
| TERT | Telomerase reverse transcriptase; maintains telomeres but also interacts with recombination regulation | Studied in Leishmania mexicana and mammalian cells |
| RAD51 | RecA-like recombinase; its activity at telomeres must be negatively regulated | Key HR factor; negative regulation prevents aberrant telomere recombination |
| RAD52 | Homologous recombination mediator; involved in ALT and telomere recombination | Target for understanding negative regulation in ALT cancers |
| BLM | RecQ helicase; resolves recombination intermediates at telomeres | Mutations cause Bloom syndrome; role in suppressing telomere recombination |
| WRN | RecQ helicase; maintains telomere stability and suppresses recombination | Defects linked to Werner syndrome and telomere dysfunction |
| FEN1 | Human homolog of Rad27; processes Okazaki fragments and R-loops | Potential role in suppressing telomere recombination |
| TERRA | Telomeric repeat-containing RNA; forms R-loops that can stimulate recombination | Its regulation is critical for negative control of telomere recombination |
| RIF1 | Shelterin-associated factor; regulates telomere length and recombination | Studied in yeast and mammalian cells for its role in telomere protection |
| RAP1 | Shelterin component; binds telomeric DNA and represses recombination | Conserved from yeast to humans; key negative regulator |
| TRF2 | Shelterin component; protects telomeres from ATM-dependent recombination | Loss leads to telomere fusions and recombination |
| POT1 | Shelterin component; binds single-stranded telomeric DNA and inhibits HR | Mutations linked to cancer predisposition |
| EXO1 | Exonuclease involved in resection; its activity at telomeres is restricted | Negative regulation prevents excessive resection and recombination |
| MRE11 | Part of MRN complex; processes DNA ends but is inhibited at telomeres | Its regulation is crucial for preventing telomere recombination |
| SGS1 | Yeast RecQ helicase; suppresses telomere recombination | Model for understanding BLM/WRN functions |
| EST1 | Telomerase-associated protein; affects telomere recombination in yeast | Studied in Ustilago maydis for telomere maintenance |
How Is negative regulation of DNA recombination at telomere Regulated?
Negative regulation of DNA recombination at telomeres is controlled at multiple levels. Epigenetic modifications, such as histone methylation and acetylation, alter chromatin accessibility and can either promote or inhibit recombination at telomeres. The presence of R-loops and their resolution by factors like Rad27/FEN1 directly impacts recombination frequency. Additionally, cell cycle checkpoints and DNA damage response pathways, including ATM/ATR signaling, modulate the recruitment of recombination factors to telomeres. Telomerase activity and cell fate decisions also influence the balance between telomere elongation and suppression of recombination. In ALT cancers, SLFN11 acts as a negative regulator that can be epigenetically silenced, leading to unchecked telomere recombination.
negative regulation of DNA recombination at telomere and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLFN11 | ALT-positive cancers; SLFN11 loss correlates with poor prognosis | CRISPR knockout in ALT cell lines (e.g., U2OS) followed by telomere recombination assays |
| WRN | Werner syndrome; premature aging and genomic instability | Knockout or point mutation in human fibroblasts; telomere FISH and recombination assays |
| BLM | Bloom syndrome; cancer predisposition and telomere dysfunction | CRISPR knockout in HEK293T; sister chromatid exchange and telomere recombination assays |
| RAD27/FEN1 | Cancer; R-loop accumulation and telomere recombination | Yeast rad27 deletion and human FEN1 knockout; R-loop detection and telomere recombination assays |
| TERT | Cancer and aging; telomerase regulation | Overexpression or knockout in cancer cell lines; telomere length and recombination assays |
Cancer and Alternative Lengthening of Telomeres (ALT)
Approximately 10-15% of cancers maintain telomeres via the ALT pathway, which relies on homologous recombination. Negative regulators of telomere recombination, such as SLFN11, are often downregulated in ALT-positive tumors, allowing uncontrolled telomere elongation and immortalization. Targeting these negative regulators or the recombination machinery they control represents a promising therapeutic strategy for ALT cancers.
Premature Aging and Telomere Dysfunction Syndromes
Defects in negative regulation of telomere recombination can lead to telomere shortening, fusions, and premature aging. Werner syndrome and Bloom syndrome, caused by mutations in WRN and BLM helicases, respectively, exhibit telomere dysfunction and increased recombination. These helicases normally suppress recombination at telomeres, and their loss results in genomic instability and accelerated aging phenotypes.
Genomic Instability and Chromosomal Rearrangements
Loss of negative regulation at telomeres leads to breakage-fusion-bridge cycles, chromosomal rearrangements, and aneuploidy, which are hallmarks of cancer and developmental disorders. Proper control of telomere recombination is essential for maintaining genome integrity across cell divisions.
From negative regulation of DNA recombination at telomere-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLFN11 increase telomere recombination? | CRISPR knockout of SLFN11 in ALT cell lines (e.g., U2OS) followed by telomere recombination assays |
| Does a point mutation in Rad27 abolish its ability to suppress telomere recombination? | Point mutation knock-in of rad27 catalytic mutant in Saccharomyces cerevisiae |
| Does overexpression of BLM suppress telomere recombination? | Overexpression of BLM in Bloom syndrome fibroblasts; telomere recombination assays |
| Does Ku80 knockout affect telomere maintenance in Leishmania? | CRISPR knockout of Ku80 in Leishmania mexicana; telomere length analysis |
| Does TERT knock-in alter telomere recombination in telomerase-negative cells? | Knock-in of TERT in ALT cells; telomere recombination and ALT assays |
| Does epigenetic modification at telomeres affect recombination? | CRISPR-dCas9 fused to histone modifiers to alter telomeric chromatin; recombination assays |
How to Study the negative regulation of DNA recombination at telomere Process
| Method | What It Measures | Typical Application |
|---|---|---|
| T-SCE assay | Frequency of telomere sister chromatid exchange | Assessing recombination at telomeres in knockout cells |
| Q-FISH | Telomere length and heterogeneity | Evaluating telomere maintenance in ALT cells |
| DRIP assay | R-loop levels at telomeres | Studying Rad27/FEN1 function in R-loop resolution |
| CRISPR knockout screen | Identification of negative regulators | Genome-wide discovery of genes suppressing telomere recombination |
| Live-cell imaging | Dynamic localization of telomere and recombination proteins | Visualizing recombination events in real time |
| Southern blot | Telomere length and terminal restriction fragments | Classic method for telomere length analysis |
| ChIP-seq | Binding of proteins to telomeric chromatin | Mapping shelterin and repair factor occupancy |
| RNA-seq | Transcriptional changes in telomere-related genes | Assessing gene expression after knockout or overexpression |
Telomere Recombination Assays
Telomere recombination can be measured using assays such as telomere sister chromatid exchange (T-SCE), telomere length analysis by Southern blot or quantitative FISH (Q-FISH), and recombination reporter systems. These methods allow researchers to quantify the frequency of recombination events at telomeres and assess the impact of gene knockouts or mutations.
R-Loop Detection and Quantification
R-loops at telomeres can be detected using the S9.6 antibody in DNA-RNA immunoprecipitation (DRIP) assays or by native gel electrophoresis. These methods are crucial for studying how factors like Rad27/FEN1 resolve R-loops to suppress recombination.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify novel negative regulators of telomere recombination. Libraries targeting DNA repair genes, helicases, and epigenetic modifiers can be introduced into ALT cell lines, followed by selection for telomere recombination phenotypes.
Live-Cell Imaging of Telomeres
Fluorescently tagged telomere proteins (e.g., TRF2-GFP) and recombination factors (e.g., RAD51-RFP) can be imaged in live cells to visualize dynamic interactions and recombination events at telomeres. This approach provides spatiotemporal insights into negative regulation.
How CRISPR Can Be Used to Study GO:0048239 negative regulation of DNA recombination at telomere
Knockout
CRISPR knockout is used to delete genes such as SLFN11, RAD27, or BLM to test whether their loss increases telomere recombination. For example, SLFN11 knockout in ALT cell lines leads to increased telomere recombination and ALT activity. Knockout of rad27 in yeast results in R-loop accumulation and elevated telomere recombination.
Point Mutation
Point mutations can be introduced to dissect catalytic or regulatory domains. For instance, mutating the catalytic residues of Rad27 abolishes its flap endonuclease activity, preventing R-loop cleavage and leading to telomere recombination. Similarly, point mutations in shelterin components like TRF2 can disrupt telomere protection and increase recombination.
Knock-in
Knock-in of tagged or mutant versions of genes allows precise tracking and functional analysis. For example, knocking in a GFP-tagged TERT enables live-cell imaging of telomerase at telomeres and assessment of its interplay with recombination. Knock-in of disease-associated mutations in WRN or BLM can model premature aging syndromes.
Overexpression
Overexpression of negative regulators such as BLM, WRN, or SLFN11 can suppress telomere recombination and inhibit ALT. This approach is used to test sufficiency of a gene in preventing recombination and to validate therapeutic targets. Overexpression of Rad27 in yeast reduces R-loop-induced recombination.
How EDITGENE Supports negative regulation of DNA recombination at telomere Research
Researchers studying negative regulation of DNA recombination at telomere-related genes often need to determine whether a candidate gene is causally involved in suppressing recombination, and whether its loss or mutation drives telomere dysfunction. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of DNA recombination at telomere research.
Frequently Asked Questions About negative regulation of DNA recombination at telomere
What is GO:0048239?
GO:0048239 is the Gene Ontology term for negative regulation of DNA recombination at telomere, defined as any process that stops, prevents, or reduces the frequency, rate or extent of genetic recombination within the telomere [QuickGO].
What genes are involved in negative regulation of DNA recombination at telomere?
Key genes include RAD27, SLFN11, KU80, TERT, RAD51, RAD52, BLM, WRN, FEN1, TERRA, RIF1, RAP1, TRF2, POT1, EXO1, MRE11, SGS1, and EST1, as supported by PubMed literature.
Why is negative regulation of telomere recombination important?
It prevents aberrant telomere lengthening, maintains genome stability, and suppresses cancer development, particularly in ALT-positive tumors.
What diseases are linked to defects in telomere recombination regulation?
Cancers utilizing ALT, Werner syndrome, Bloom syndrome, and other premature aging syndromes are linked to defects in negative regulation of telomere recombination.
How can I study negative regulation of DNA recombination at telomere?
Methods include telomere recombination assays (T-SCE, Q-FISH), R-loop detection (DRIP), CRISPR screens, live-cell imaging, and ChIP-seq.
What is the role of SLFN11 in telomere recombination?
SLFN11 acts as a brake on alternative lengthening of telomeres by suppressing recombination; its loss leads to increased ALT activity.
How does Rad27 suppress telomere recombination?
Rad27 cleaves the RNA of R-loop structures at telomeres, preventing RNA-DNA hybrids from initiating homologous recombination.
Can CRISPR be used to study negative regulation of telomere recombination?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function in this process.
What are the consequences of losing negative regulation at telomeres?
Loss leads to telomere length heterogeneity, chromosomal fusions, breakage-fusion-bridge cycles, and genomic instability.
Which model organisms are used to study GO:0048239?
Saccharomyces cerevisiae, Ustilago maydis, Leishmania mexicana, and human cell lines are commonly used to study telomere recombination regulation.
Conclusion
GO:0048239, negative regulation of DNA recombination at telomere, is a critical biological process that safeguards genome stability by suppressing aberrant recombination at chromosome ends. Dysregulation of this process is implicated in cancer, particularly ALT-positive tumors, and premature aging syndromes. Advances in CRISPR-based gene editing and high-throughput screening are accelerating the discovery of new regulators and therapeutic targets. EDITGENE provides the tools and expertise to generate precise cell models for studying this process, empowering researchers to translate basic findings into clinical applications.
References
- 1. Yu EY et al.. 2018. Contributions of recombination and repair proteins to telomere maintenance in telomerase-positive and negative Ustilago maydis.. Mol Microbiol 107(1):81-93 PMID: 29052918
- 2. Chowdary KVSKA et al.. 2023. Epigenetic regulation during meiosis and crossover.. Physiol Mol Biol Plants 29(12):1945-1958 PMID: 38222277
- 3. Khandagale P et al.. 2025. SLFN11 puts the brakes on Alternative lengthening of telomeres.. bioRxiv PMID: 41427320
- 4. Aguilera P et al.. 2023. NPCs and APBs: two HUBs of non-canonical homology-based recombination at telomeres?. Cell Cycle 22(10):1163-1168 PMID: 37128641
- 5. Wood-Trageser MA et al.. 2025. Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.. Mod Pathol 38(10):100863 PMID: 40784487
- 6. Alpizar-Sosa EA et al.. 2025. Leishmania mexicana telomeres at high resolution: Ku80, TERT, and alternative lengthening mechanisms.. BMC Genomics 26(1):955 PMID: 41345908
- 7. Liu CC et al.. 2023. Flap endonuclease Rad27 cleaves the RNA of R-loop structures to suppress telomere recombination.. Nucleic Acids Res 51(9):4398-4414 PMID: 36999631
- 8. Cukusić A et al.. 2008. Telomerase regulation at the crossroads of cell fate.. Cytogenet Genome Res 122(3-4):263-72 PMID: 19188695
